Bonk, Inc. (BNKK)
NASDAQ: BNKK · Real-Time Price · USD
2.140
-0.040 (-1.83%)
At close: May 15, 2026, 4:00 PM EDT
2.170
+0.030 (1.40%)
After-hours: May 15, 2026, 7:49 PM EDT
Company Description
Bonk, Inc. provides over-the-counter products and consumer products in the United States.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content to allow recovery from the effects of alcohol by supporting its metabolism.
It also provides hair loss treatment, vitiligo solution, and sexual wellness products. The company sells its products through direct customers, distributors, retailers, and e-commerce websites.
The company was formerly known as Safety Shot, Inc. and changed its name to Bonk, Inc. in October 2025.
Bonk, Inc. was incorporated in 2018 and is headquartered in Scottsdale, Arizona.
Bonk, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 10 |
| CEO | Jarrett Boon |
Contact Details
Address: 18801 N. Thompson Peak, Suite 380 Scottsdale, Arizona 85255 United States | |
| Phone | 888 257 8061 |
| Website | bonkdat.com |
Stock Details
| Ticker Symbol | BNKK |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1760903 |
| CUSIP Number | 48208F105 |
| ISIN Number | US48208F3038 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| Markita L. Russell | Chief Financial Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2026 | 10-Q | Quarterly Report |
| May 1, 2026 | EFFECT | Notice of Effectiveness |
| Apr 30, 2026 | 8-K | Current Report |
| Apr 28, 2026 | 8-K | Current Report |
| Apr 17, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 31, 2026 | 10-K | Annual Report |
| Feb 3, 2026 | 424B3 | Prospectus |
| Jan 30, 2026 | EFFECT | Notice of Effectiveness |
| Jan 28, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 14, 2026 | 8-K | Current Report |